Candy Place Chocolate Santas, in 11 oz clear plastic bags, individually wrapped assortment of double chocolate, caramel, and peanut butt...
⚠ Critical Alert — Stop Using Immediately
This product has been flagged with severe risks (undeclared allergen). Stop using it now and contact the brand or FDA for a refund, repair, or replacement.
FDA Recall Notice
Source: U.S. Food and Drug Administration (FDA) — official FDA notice for recall FDA-F-1438-2014.
Giant Eagle Candy Place Chocolate Santas do not declare the peanut allergen ingredient on the primary package label. Also, the caramel variety ingredient statement was not included in the finished product label.
Corrective Action (per FDA)
Source: U.S. Food and Drug Administration (FDA) — official FDA notice for recall FDA-F-1438-2014.
Recall terminated by FDA.
✅ What you should do
- Stop using the product if you own it.
- Check the model number, lot code, or sell-by date against the recall notice above.
- Contact Giant Eagle or the retailer where you bought it for a refund, replacement, or repair.
- For the most current official instructions, visit the FDA recall page.
- If you've been hurt by this product, report the incident to FDA.
Consumer Contact (per FDA)
Source: U.S. Food and Drug Administration (FDA) — official FDA notice for recall FDA-F-1438-2014.
Giant Eagle
About the U.S. Food and Drug Administration
The FDA regulates drugs, medical devices, food, cosmetics, and tobacco. Adverse event reports and recall notices are the main public safety signal.
Visit FDA.gov →📣 Report a food, supplement, or cosmetic problem to the FDA
If you had a reaction, found contamination, or experienced a labeling problem with this product, report it to the FDA. The agency uses consumer reports to track emerging safety signals and trigger recalls.
Giant Eagle Recall FAQ
Giant Eagle is the subject of a dairy safety report: Candy Place Chocolate Santas, in 11 oz clear plastic bags, individually wrapped assortment of double chocolate, caramel, and peanut butt.... The notice was published on December 27, 2013 by the U.S. Food and Drug Administration (FDA). Approximately 1,372 units are potentially affected.